Tag: mpMRI

Proton beam therapy for prostate cancer has been struggling with insurance issues because it is significantly more costly than conventional radiation types, yet has not demonstrated better cancer control. However, in the minds of many patients, it offers a better chance at cure... keep reading

The growing use of terms like “indolent PCa” and “insignificant PCa” signal recognition that a) not every low-risk PCa tumor needs to be treated immediately, and b) some PCa tumors may never need to be treated at all! keep reading

Good news! The widespread integration of multiparametric MRI (mpMRI) and MRI-guided targeted biopsies has resulted in both better initial qualification of AS candidates, and significantly better ability to monitor for significant PCa by PSA + mpMRI. As a side benefit... keep reading

No one can dispute the superiority of multiparametric MRI (mpMRI) over transrectal ultrasound (TRUS) for detecting and characterizing prostate cancer (PCa) before biopsy and treatment. The past five years alone have seen a rapid accumulation of research evidence that mpMRI makes it possible to save medical dollars by avoiding unnecessary biopsies and their risks. While keep reading

A new PI-RADS version improves earlier guidelines for more consistent image acquisition, interpretation, scoring and reporting... keep reading

What comes to mind when you hear the expression “post traumatic stress disorder” or PTSD? Perhaps it conjures up images of war veterans, crime victims, or natural disasters. We recognize that when something beyond a person’s control creates sudden or catastrophic harm, the person is shaken by it, often deeply. Trauma is defined as a keep reading